Seegene, Inc.
096530.KQ
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.74T
Close$
$13194.25
64% downside
Current Fair Value
64% downsideOvervalued by 64% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.74 Trillion |
|---|---|
| Enterprise Value | $1.60 Trillion |
| Dividend Yield | $1200.00 (3.15%) |
| Earnings per Share | $1047 |
| Beta | 0.88 |
| Outstanding Shares | 52,260,000 |
Return
| Return on Equity | 7.72% |
|---|---|
| Return on Assets | 6.33% |
| Return on Invested Capital | 6.97% |
Valuation & Multiples
| P/E Ratio | 21.93 |
|---|---|
| PEG | -0.1 |
| Price to Sales | 3.77 |
| Price to Book Ratio | 1.85 |
| Enterprise Value to Revenue | 3.15 |
| Enterprise Value to EBIT | 21.12 |
| Enterprise Value to Net Income | 19 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
$568.32
Average shareholder expectationRevenue Estimate
$134.40 B
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$670.73
Average shareholder expectationRevenue Estimate
$137.40 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Seegene, Inc.
822 employees
CEO: Jong-Yoon Cheon Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastroint...